Swiss Pharmaceuticals & Biotech Profitable Climbers

SKAN Group

Market Cap: CHF 999.4m

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Kuros Biosciences

Market Cap: CHF 957.4m

Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.

Galderma Group

Market Cap: CHF 37.5b

Operates as a dermatology company worldwide.

Basilea Pharmaceutica

Market Cap: CHF 669.9m

A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.